Wednesday, February 19, 2025 | 09:50 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Suven Pharma stock can surge up to 19% from here; check key levels

Technical charts suggest that Suven Pharma may trade with a positive bias in the near-term, provided the stock manages to hold above these key support levels.

pharmaceutical sector, pharma sector, medicines, meds
Premium

Photo: Bloomberg

Rex Cano Mumbai

Listen to This Article

Suven Pharma stock has under-performed both its benchmark NSE Smallcap index and the sectoral Nifty Pharma index so far this year. The stock has shed 13.5 per cent as against a rally of 8 per cent on the SmallCap index and a 10.5 per cent gain on the Nifty Pharma.

The stock has underperformed owing to sub-par earnings in the December quarter. Suven Pharma company posted a profit of Rs 5.24 crore for the December 2023 quarter, down 52.1 per cent when compared with a profit of Rs 10.95 crore in the corresponding quarter a year ago. Total income declined

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in